479 related articles for article (PubMed ID: 28987689)
21. Correlation of survival length after pancreaticoduodenectomy for pancreatic head adenocarcinoma depending on tumor characteristics detected by means of computed tomography and resection margins status.
Prochazka V; Hlavsa J; Kunovsky L; Farkasova M; Potrusil M; Andrasina T; Litavcova A; Mazanec J; Dolina J; Ostrizkova L; Eid M; Kovalcikova P; Pavlik T; Kala Z
Neoplasma; 2020 Nov; 67(6):1319-1328. PubMed ID: 32614234
[TBL] [Abstract][Full Text] [Related]
22. Defining venous involvement in borderline resectable pancreatic cancer.
Chun YS; Milestone BN; Watson JC; Cohen SJ; Burtness B; Engstrom PF; Haluszka O; Tokar JL; Hall MJ; Denlinger CS; Astsaturov I; Hoffman JP
Ann Surg Oncol; 2010 Nov; 17(11):2832-8. PubMed ID: 20725860
[TBL] [Abstract][Full Text] [Related]
23. A tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer: influence on borderline resectable.
Marinelli T; Filippone A; Tavano F; Fontana A; Pellegrini F; Köninger J; Richter GM; Bonomo L; Büchler MW; di Sebastiano P; di Mola FF
Radiol Med; 2014 May; 119(5):334-42. PubMed ID: 24619824
[TBL] [Abstract][Full Text] [Related]
24. National Comprehensive Cancer Network Resectability Status for Pancreatic Carcinoma Predicts Overall Survival.
Murakami Y; Satoi S; Sho M; Motoi F; Matsumoto I; Kawai M; Honda G; Uemura K; Yanagimoto H; Shinzeki M; Kurata M; Kinoshita S; Yamaue H; Unno M
World J Surg; 2015 Sep; 39(9):2306-14. PubMed ID: 26013206
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
[TBL] [Abstract][Full Text] [Related]
26. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion.
Wang WL; Ye S; Yan S; Shen Y; Zhang M; Wu J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):429-35. PubMed ID: 26256089
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma.
Giovinazzo F; Turri G; Katz MH; Heaton N; Ahmed I
Br J Surg; 2016 Feb; 103(3):179-91. PubMed ID: 26663252
[TBL] [Abstract][Full Text] [Related]
28. Prognostic role of the length of tumour-vein contact at the portal-superior mesenteric vein in patients having surgery for pancreatic cancer.
Imamura T; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Todaka A; Fukutomi A; Aramaki T; Uesaka K
Br J Surg; 2019 Nov; 106(12):1649-1656. PubMed ID: 31626342
[TBL] [Abstract][Full Text] [Related]
29. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients.
Ramacciato G; Nigri G; Petrucciani N; Pinna AD; Ravaioli M; Jovine E; Minni F; Grazi GL; Chirletti P; Tisone G; Napoli N; Boggi U
Ann Surg Oncol; 2016 Jun; 23(6):2028-37. PubMed ID: 26893222
[TBL] [Abstract][Full Text] [Related]
30. Pancreatoduodenectomy with venous resection for ductal adenocarcinoma rarely achieves complete (R0) resection.
Kleive D; Labori KJ; Line PD; Gladhaug IP; Verbeke CS
HPB (Oxford); 2020 Jan; 22(1):50-57. PubMed ID: 31186199
[TBL] [Abstract][Full Text] [Related]
31. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
Lee DH; Ha HI; Jang JY; Lee JW; Choi JY; Bang S; Lee CH; Kim WB; Lee SS; Kim SC; Kang BK; Lee JM
Eur Radiol; 2023 Sep; 33(9):5965-5975. PubMed ID: 36988715
[TBL] [Abstract][Full Text] [Related]
32. Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion.
Park SJ; Jang S; Han JK; Kim H; Kwon W; Jang JY; Lee KB; Kim H; Lee DH
Eur Radiol; 2021 Sep; 31(9):6889-6897. PubMed ID: 33740095
[TBL] [Abstract][Full Text] [Related]
33. Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy.
Javed AA; Wright MJ; Siddique A; Blair AB; Ding D; Burkhart RA; Makary M; Cameron JL; Narang A; Herman J; Zheng L; Laheru D; Weiss MJ; Wolfgang C; He J
J Gastrointest Surg; 2019 Jan; 23(1):112-121. PubMed ID: 30242644
[TBL] [Abstract][Full Text] [Related]
34. CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy.
Jang JK; Byun JH; Kang JH; Son JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Kim SC; Lee MG
Eur Radiol; 2021 Feb; 31(2):813-823. PubMed ID: 32845389
[TBL] [Abstract][Full Text] [Related]
35. Modified National Comprehensive Cancer Network Criteria for Assessing Resectability of Pancreatic Ductal Adenocarcinoma.
Noda Y; Goshima S; Kawada H; Kawai N; Miyoshi T; Matsuo M; Bae KT
AJR Am J Roentgenol; 2018 Jun; 210(6):1252-1258. PubMed ID: 29629801
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of resections for pancreatic adenocarcinoma with suspected venous involvement: a single center experience.
Michalski CW; Kong B; Jäger C; Kloe S; Beier B; Braren R; Esposito I; Erkan M; Friess H; Kleeff J
BMC Surg; 2015 Aug; 15():100. PubMed ID: 26296752
[TBL] [Abstract][Full Text] [Related]
37. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C
Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211
[TBL] [Abstract][Full Text] [Related]
38. Utility of Dark-Blood Dual-Energy CT Images for Predicting Vascular Involvement and R0 Resection in Patients With Pancreatic Cancer.
Si K; Wu H; Yang M; Guo Y; Zhang X; Ding C; Xue J; Han P; Li X
AJR Am J Roentgenol; 2023 Jun; 220(6):838-848. PubMed ID: 36541594
[No Abstract] [Full Text] [Related]
39. Resection of the Portal-Superior Mesenteric Vein in Pancreatic Cancer: Pathological Assessment and Recurrence Patterns.
Groen JV; van Manen L; van Roessel S; van Dam JL; Bonsing BA; Doukas M; van Eijck CHJ; Farina Sarasqueta A; Putter H; Vahrmeijer AL; Verheij J; Besselink MG; Groot Koerkamp B; Mieog JSD
Pancreas; 2021 Sep; 50(8):1218-1229. PubMed ID: 34714287
[TBL] [Abstract][Full Text] [Related]
40. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.
van Geenen RC; ten Kate FJ; de Wit LT; van Gulik TM; Obertop H; Gouma DJ
Surgery; 2001 Feb; 129(2):158-63. PubMed ID: 11174708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
